LBF15306CV02: Difference between revisions

No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 6: Line 6:
|LipidBank=XPR8045
|LipidBank=XPR8045
|LipidMaps=LMFA03120026
|LipidMaps=LMFA03120026
|SysName= trans-2- [(R)-2-Acetoxy-2- [cis-2-octenyl] -5-oxo-3-cyclopentenylidene] acetaldehyde
|SysName=trans-2- [2R -Acetoxy-2- (cis-2-octenyl) -5-oxo-3-cyclopentenylidene] acetaldehyde
|Common Name=&&clavirin II&&(E)-2- [(R)-2-Acetoxy-2- [(Z)-2-octenyl] -5-oxo-3-cyclopentenylidene] acetaldehyde&&
|Common Name=&&Clavirin II &&2E- [2R-Acetoxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene] acetaldehyde&&
|Optical=[ alpha ]_D  -33.7°(C 0.43, CHCl_3 )[[Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455|{{RelationTable/GetFirstAuthor|Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455}}]]
|Optical=[ alpha ]_D  -33.7°(C 0.43, CHCl_3 )[[Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455|{{RelationTable/GetFirstAuthor|Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455}}]]
|NMR Spectra=^1 H-NMR(500MHz,CDCl_3 ) delta ppm0.88(3H,t,J=7.1Hz),1.20-1.40(6H,m),1.95(2H,brq,J=7.2Hz),2.09(3H,s),2.88(1H,dd,J=7.1,14.5Hz),2.91(1H,dd,J=7.5,14.5Hz),5.23(1H,ddd,J=1.6,7.2,10.9Hz),5.62(1H,ddd,J=7.1,7.5,10.9Hz),6.53(1H,d,J=8.0Hz),6.54(1H,d,J=6.2Hz),7.65(1H,d,J=6.2Hz),10.33(1H,d,J=8.0Hz).[[Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455|{{RelationTable/GetFirstAuthor|Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455}}]] ^{13}C-NMR(125MHz,CDCl_3 ) delta ppm14.0,21.3,22.5,27.5,28.9,31.4,37.3,84.4,120.1,125.6,134.8,136.5,149.4,159.3,169.2,190.6,192.5.[[Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455|{{RelationTable/GetFirstAuthor|Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455}}]]
|NMR Spectra=^1 H-NMR(500MHz,CDCl_3 ) delta ppm0.88(3H,t,J=7.1Hz),1.20-1.40(6H,m),1.95(2H,brq,J=7.2Hz),2.09(3H,s),2.88(1H,dd,J=7.1,14.5Hz),2.91(1H,dd,J=7.5,14.5Hz),5.23(1H,ddd,J=1.6,7.2,10.9Hz),5.62(1H,ddd,J=7.1,7.5,10.9Hz),6.53(1H,d,J=8.0Hz),6.54(1H,d,J=6.2Hz),7.65(1H,d,J=6.2Hz),10.33(1H,d,J=8.0Hz).[[Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455|{{RelationTable/GetFirstAuthor|Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455}}]] ^{13}C-NMR(125MHz,CDCl_3 ) delta ppm14.0,21.3,22.5,27.5,28.9,31.4,37.3,84.4,120.1,125.6,134.8,136.5,149.4,159.3,169.2,190.6,192.5.[[Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455|{{RelationTable/GetFirstAuthor|Reference:Iwashima_M:Okamoto_K:Iguchi_K:,Tetrahedron Lett.,1999,40,6455}}]]

Latest revision as of 05:35, 21 October 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



Clavirin II
LBF15306CV02.png
Structural Information
trans-2- [2R -Acetoxy-2- (cis-2-octenyl) -5-oxo-3-cyclopentenylidene] acetaldehyde
  • Clavirin II
  • 2E- [2R-Acetoxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene] acetaldehyde
Formula C17H22O4
Exact Mass 290.151809192
Average Mass 290.35418
SMILES CCCCCC=CC[C@](OC(C)=O)(C=1)C(=CC=O)C(=O)C1
Physicochemical Information
[ α ]D -33.7°(C 0.43, CHCl3) IwashimaMet al.
Clavirins were isolated from Japanese soft coral, Stolonifer Clavularia viridis Quoy and Gaimard. Iwashima_M et al.
Clavirin I and II were synthesized from 4-alkoxy-2-cyclopentenone. Iwashima_M et al.
Clavirins may possibly be biosynthesized from clavulone. Iwashima_M et al.
Clavirins showed growth-inhibitory activity toward Hela S3 at 1 mu g/ml. Iwashima_M et al.
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra 1H-NMR(500MHz,CDCl3) δ ppm0.88(3H,t,J=7.1Hz),1.20-1.40(6H,m),1.95(2H,brq,J=7.2Hz),2.09(3H,s),2.88(1H,dd,J=7.1,14.5Hz),2.91(1H,dd,J=7.5,14.5Hz),5.23(1H,ddd,J=1.6,7.2,10.9Hz),5.62(1H,ddd,J=7.1,7.5,10.9Hz),6.53(1H,d,J=8.0Hz),6.54(1H,d,J=6.2Hz),7.65(1H,d,J=6.2Hz),10.33(1H,d,J=8.0Hz). IwashimaMet al. 13C-NMR(125MHz,CDCl3) δ ppm14.0,21.3,22.5,27.5,28.9,31.4,37.3,84.4,120.1,125.6,134.8,136.5,149.4,159.3,169.2,190.6,192.5. IwashimaMet al.
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF15306CV02 See above. Iwashima_M et al. 1999